Advertisement
Collaboration › Details
Basilea–Coulter Partners: recruitment services, 201807 supply service placement of Gerrit Hauck as new CTO of Basilea Pharmaceutica Intl Ltd
Period | 2018-07-04 | |
Partner, 1st | Basilea Pharmaceutica International Ltd. | |
Group | Basilea (Group) | |
Partner, 2nd | Coulter Partners, Zurich | |
Group | Coulter Partners (The Coulter Partnership Ltd.) | |
Product | pharmaceutical | |
Person | Hauck, Gerrit (Basilea 201807– CTO before Sanofi) | |
Person 2 | Buis, Philipp (Coulter Partners 201703– Executive Director in Zurich before Jauch Assoc + Ward Howell/Neumann Intl) | |
Coulter Partners. (7/4/18). "Press Release: Coulter Partners Secures Chief Technology Officer for Basilea Pharmaceutica International Ltd.".
“We are very pleased that Dr. Gerrit Hauck has assumed the role of Chief Technology Officer at Basilea and thank the team at Coulter Partners for their outstanding professional work in helping us to achieve this appointment. Dr. Hauck has over 24 years of experience in various technical operations and management functions at Sanofi and its predecessor companies, which involved formulation development, plant management and global CMC leadership. He has demonstrated his ability to manage contract manufacturing organizations and to successfully develop alliances and collaborations with external partners.”
David Veitch – CEO, Basilea Pharmaceutica International Ltd.
KEY PLAYERS
Graham Johnson : Client Partner
Philipp Buis : Executive Director
Marie-Garance Leroy : Senior Consultant
Emma Hiom : Director, Production
Hélène Johnson : Executive Assistant
Record changed: 2018-07-14 |
Advertisement
More documents for Basilea (Group)
- [1] Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Announces Acquisition of Basilea Pharmaceutica’s PARG Inhibitor Programme". Edinburgh....
- [2] Coulter Partners. (7/4/18). "Press Release: Coulter Partners Secures Chief Technology Officer for Basilea Pharmaceutica International Ltd."....
- [3] Basilea Pharmaceutica Ltd.. (3/1/18). "Press Release: Basilea Names Adesh Kaul as New Member of its Management Committee". Basel....
- [4] Basilea Pharmaceutica Ltd.. (2/27/18). "Press Release: Basilea Reports Significantly Improved Financial Results in 2017". Basel....
- [5] Basilea Pharmaceutica Ltd.. (2/23/18). "Press Release: Basilea Reports Clinical Phase 3 Study Start with Antibiotic Ceftobiprole in Skin Infections under BARDA Contract". Basel....
- [6] Basilea Pharmaceutica Ltd.. (2/21/18). "Press Release: Basilea's CEO Ronald Scott Will Retire. Chief Commercial Officer David Veitch Named as Successor – Changes in the Board of Directors". Basel....
- [7] Basilea Pharmaceutica Ltd.. (1/10/18). "Press Release: Basilea Announces Completion of the License Agreement Extension with Pfizer for Antifungal Cresemba for China and Asia Pacific". Basel....
- [8] Basilea Pharmaceutica Ltd.. (12/1/17). "Press Release: Basilea Extends Existing License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) to China and Asia Pacific". Basel....
- [9] Basilea Pharmaceutica Ltd.. (9/28/17). "Press Release: Basilea Announces License Agreement for Antibiotic Zevtera (ceftobiprole) with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd.". Basel....
- [10] Basilea Pharmaceutica Ltd.. (8/10/17). "Press Release: Basilea Reports Improved Financial Results in Half-year 2017 Driven by Growing Product Sales, Significant Progress on Partnering and Development Programs". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top